Presentación

Últimos Comentarios

Etiquetas

Artículos Aleatorios

• Clínical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Failure 2012 .Feb.
• Presentación del blog
• Prevalence of, Associations With and Prognostic Value of TAPSE Among Out Patients Refered for Evaluation of Heart failure
• Impact of Chronic Obstructuive Pulmonary Disease Severity on Symptoms and Prognosis in Patients with Systolic Heart Disease. Arnaudis B et al. Clin Res Cardiol 2012. DOI: 10.1007/s00392-012-0450-4
• Predictors of Mortality in 6975 Patients with chronic Heart Failure in the GISSI-HF Trial: Proposal for a Nomogram. Circ Heart Fail 2012. Nov 14.
• NT-ProBNP independely predicts long term mortality after acute exacervation of COPD – a prospective cohort study. respir Res 2012.Oct 29;13:97.
• Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol 2010;55:1780-7.
• Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Maeder MT, Kaye DM. International Journal of Cardiology (2012) 155:2 (249-256).
• Assosciation between b-blocker therapy and outcomes in patients hospitalised with acute exacerbations of COPD with underliying ischemic heart disease, HF or hypertension. Stefan MS et al. Throrax 2012. Aug 31.
• Determinants of mortality in patients with heart failure and atrial fibrillation during long term follow up. Acta Cardiol 2011;66(6):751-7.

Artículos Recientes

• NT-ProBNP independely predicts long term mortality after acute exacervation of COPD – a prospective cohort study. respir Res 2012.Oct 29;13:97.
• Predictors of Mortality in 6975 Patients with chronic Heart Failure in the GISSI-HF Trial: Proposal for a Nomogram. Circ Heart Fail 2012. Nov 14.
• Assosciation between b-blocker therapy and outcomes in patients hospitalised with acute exacerbations of COPD with underliying ischemic heart disease, HF or hypertension. Stefan MS et al. Throrax 2012. Aug 31.
• Impact of Chronic Obstructuive Pulmonary Disease Severity on Symptoms and Prognosis in Patients with Systolic Heart Disease. Arnaudis B et al. Clin Res Cardiol 2012. DOI: 10.1007/s00392-012-0450-4
• Bonchodilators in Heart failure Patients with COPD: Is it the Time for a Clínical Trial. Mentz et al. J Card Fail 2012;18(5).413-22.
• Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Maeder MT, Kaye DM. International Journal of Cardiology (2012) 155:2 (249-256).
• Prevalence of, Associations With and Prognostic Value of TAPSE Among Out Patients Refered for Evaluation of Heart failure
• Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol 2010;55:1780-7.
• Determinants of mortality in patients with heart failure and atrial fibrillation during long term follow up. Acta Cardiol 2011;66(6):751-7.
• Clínical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Failure 2012 .Feb.